1C18: Brazilian purpuric fever

The ICD-11 code 1C18 refers to Brazilian purpuric fever, a rare infectious disease primarily affecting children in Brazil. This condition is characterized by symptoms such as high fever, rash, and purpura, or small bleeding spots under the skin. Brazilian purpuric fever is caused by the bacteria Haemophilus influenzae biogroup aegyptius, which is transmitted through respiratory secretions.

The disease typically begins with flu-like symptoms, such as fever, chills, and headache, before progressing to more severe symptoms like joint pain, vomiting, and diarrhea. The hallmark sign of Brazilian purpuric fever is the development of a purpuric rash, which may start as small red spots before evolving into larger patches of skin discoloration. In some cases, patients may also experience swelling of the face, hands, and feet.

Early diagnosis and treatment of Brazilian purpuric fever are crucial to prevent complications such as sepsis, meningitis, or death. Antibiotics are the mainstay of treatment for this bacterial infection, with supportive care such as fluids and pain management also being important for recovery. While Brazilian purpuric fever is rare, public health efforts to monitor and control the spread of Haemophilus influenzae infections remain important in regions where the disease is endemic.

Table of Contents:

#️⃣  Coding Considerations

The equivalent SNOMED CT code for the ICD-11 code 1C18, which represents Brazilian purpuric fever, is 416704005. SNOMED CT, a comprehensive clinical terminology system used globally, provides a standardized way to exchange health information. This specific code is unique to Brazilian purpuric fever, an infectious disease primarily affecting children, characterized by fever, rash, and petechiae. By utilizing SNOMED CT codes, healthcare professionals can accurately document and track patient diagnoses, treatments, and outcomes. Such coding systems are crucial for ensuring interoperability and consistency in healthcare data across different platforms and settings. With the growing complexity and volume of health information, standardized codes like SNOMED CT help streamline communication and improve patient care.

In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.

The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.

🔎  Symptoms

Symptoms of 1C18, also known as Brazilian purpuric fever, typically begin with the sudden onset of a high fever, often exceeding 39 degrees Celsius. Patients may also experience lethargy, irritability, and poor appetite. In some cases, there may be initial symptoms such as sore throat or cough.

As the disease progresses, affected individuals may develop a characteristic purpuric rash, which consists of small, red or purple spots on the skin that do not fade with pressure. This rash often starts on the limbs and spreads to the trunk and face. In severe cases, the rash can progress to large areas of skin discoloration and may be accompanied by areas of skin necrosis.

Other common symptoms of 1C18 include abdominal pain, vomiting, and diarrhea. Some patients may also present with signs of sepsis, such as rapid heart rate, rapid breathing, and low blood pressure. Additionally, individuals with Brazilian purpuric fever may exhibit signs of meningitis, such as neck stiffness, headache, and altered mental status. Prompt medical attention is crucial to prevent complications and improve outcomes for patients with this potentially life-threatening condition.

🩺  Diagnosis

Diagnosis of 1C18 (Brazilian purpuric fever) is primarily clinical and based on the presentation of symptoms. Patients typically present with fever, rash, petechiae, and signs of systemic sepsis. The disease progresses rapidly, and early recognition is crucial for timely intervention.

Laboratory testing plays a key role in confirming the diagnosis of Brazilian purpuric fever. Blood cultures are essential for identifying the causative agent, Haemophilus influenzae biogroup aegyptius. Additionally, complete blood count (CBC) may reveal leukocytosis, thrombocytopenia, and anemia, which are common findings in patients with this condition.

In some cases, skin biopsy may be performed to support the diagnosis of Brazilian purpuric fever. The characteristic histopathological findings include perivascular and interstitial infiltrates of neutrophils and lymphocytes, as well as fibrinoid necrosis of vessel walls. These findings, in conjunction with clinical symptoms and laboratory results, contribute to a definitive diagnosis of 1C18.

💊  Treatment & Recovery

Treatment for 1C18, commonly known as Brazilian purpuric fever, typically involves a combination of antibiotics and supportive care. The antibiotic of choice is usually ceftriaxone, given intravenously at high doses. This helps to target the bacterial infection causing the fever and prevent further complications.

In severe cases of Brazilian purpuric fever, patients may require hospitalization for close monitoring and management of symptoms. Supportive care may include hydration, pain management, and treatment of any complications that arise. It is important for patients to receive prompt and appropriate medical care to improve their chances of recovery.

Recovery from Brazilian purpuric fever can vary depending on the severity of the infection and the overall health of the patient. In some cases, patients may experience lingering symptoms or complications even after completing a course of antibiotics. It is important for patients to follow up with their healthcare providers for ongoing monitoring and support during the recovery process.

🌎  Prevalence & Risk

In the United States, Brazilian purpuric fever is an extremely rare disease. Only a handful of cases have been reported, making it difficult to determine an accurate prevalence rate. The disease is mostly confined to isolated outbreaks in specific regions and does not pose a significant public health concern at a national level.

In Europe, cases of Brazilian purpuric fever are even rarer than in the United States. The disease is virtually unheard of in most European countries, with only a few sporadic cases reported over the years. The lack of cases in Europe can be attributed to the geographical distance between the continent and the primary endemic areas in Brazil.

In Asia, Brazilian purpuric fever is also considered to be a rare disease. While there have been reports of isolated cases in countries like Japan and South Korea, the prevalence remains low. The disease is not endemic to Asia and is unlikely to become a major health issue in the region.

Similarly, in Africa, Brazilian purpuric fever is a rare disease with very few reported cases. The disease is not endemic to the continent, and the risk of transmission is low. African countries are more concerned with other infectious diseases that pose a greater threat to public health, making Brazilian purpuric fever a minor concern in the region.

😷  Prevention

To prevent 1C18 (Brazilian purpuric fever), it is crucial to take several preventative measures. First and foremost, maintaining good personal hygiene is essential. This includes frequent handwashing with soap and water, especially after using the restroom and before eating. Avoiding close contact with individuals who are infected with Haemophilus influenzae type b, the bacterium that causes 1C18, is also crucial in preventing transmission of the disease.

Vaccination against Haemophilus influenzae type b is another important preventive measure to consider. This vaccine, known as the Hib vaccine, is highly effective in protecting individuals from developing severe infections, including Brazilian purpuric fever. Ensuring that individuals are up-to-date on their vaccinations, particularly infants and young children who are most vulnerable to the disease, is crucial in preventing outbreaks of 1C18.

Additionally, practicing safe sex and using protection, such as condoms, can help prevent the transmission of sexually transmitted infections that can lead to Brazilian purpuric fever. Education about the risks associated with 1C18 and the importance of prevention methods is also essential in controlling the spread of the disease. By implementing these preventive measures, individuals can reduce their risk of contracting 1C18 and help prevent outbreaks in the community.

1C18 (Brazilian purpuric fever) is a specific code used to identify a rare disease characterized by acute fever, purpura, and shock. This condition is caused by infection with Haemophilus influenzae biogroup aegyptius. Similar diseases that may present with similar symptoms include sepsis, meningococcemia, and Rocky Mountain spotted fever.

Sepsis, also known as blood poisoning, is a life-threatening condition caused by the body’s response to an infection. Symptoms of sepsis can include fever, rapid heart rate, and confusion. In severe cases, sepsis can progress to septic shock, leading to organ failure and death.

Meningococcemia is a bacterial infection caused by Neisseria meningitidis, a common cause of meningitis. Symptoms of meningococcemia can include sudden onset of fever, rash, and rapid breathing. This infection can progress rapidly, leading to septicemia, meningitis, and potentially death if not treated promptly.

Rocky Mountain spotted fever is a tick-borne disease caused by the bacterium Rickettsia rickettsii. Symptoms of Rocky Mountain spotted fever can include fever, headache, and rash. If left untreated, this disease can lead to serious complications such as organ failure and death. It is important to seek medical attention promptly if you suspect you have been exposed to any of these diseases.

You cannot copy content of this page